A Study of the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected Patients

NCT01586325 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class

Stopped Because of many competing trials using the same mechanism of action, but being further advanced in development

Conditions

Interventions

Sponsor

Janssen R&D Ireland